Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether the cramp comfort patch is classifiable under HSN 3004 as a medicament or under HSN 3005 as wadding, gauze, bandages and similar articles for medical purposes, and the consequential GST rate applicable.
Analysis: The product was examined under the tariff headings in Notification No. 01/2017-Central Tax (Rate) and the corresponding Tamil Nadu notification, with the HSN explanatory notes treated as relevant interpretative aids. The product was found to be a self-heating patch used for relief of menstrual pain, but its ingredients and mode of use were not shown to make it a medicament consisting of mixed or unmixed products for therapeutic or prophylactic use in the sense required by heading 3004. The claimed therapeutic character and reference to drug-law definitions were held insufficient to establish classification as a medicament. The product, however, was considered to answer the description of a similar article falling within heading 3005, being a patch used for medical purposes and put up for retail sale for pain relief.
Conclusion: The cramp comfort patch is classifiable under HSN 3005 and not under HSN 3004; the applicable GST rate is 12% under serial no. 64 of Schedule II.
Final Conclusion: The ruling settles the product classification in favour of heading 3005 and applies the corresponding concessional rate for articles used for medical purposes.
Ratio Decidendi: A self-heating patch used for pain relief is not a medicament under heading 3004 merely because it has a therapeutic purpose; where it is marketed and used as a medical-purposes article answering the tariff description of heading 3005, it is to be classified there.